Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Leukemia, Acute Myelogenous”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT03600558
What this trial is testing

Efficacy of FLAG Regimen for the Treatment of Patients With AML

Who this might be right for
LeukemiaLeukemia, MyeloidLeukemia, Myeloid, Acute
Tianjin Medical University General Hospital 60
Not applicableStudy completedNCT03881826
What this trial is testing

Investigation of the Gut Microbiota in Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaCachexia
Université Catholique de Louvain 60
Large-scale testing (Phase 3)UnknownNCT05175508
What this trial is testing

Aza With or Without ATRA in Newly Diagnosed Unfit AML or Intermediate,High or Very High Risk MDS

Who this might be right for
AMLMDSOld Age; Debility+1 more
The First Affiliated Hospital of Soochow University 180
Not applicableUnknownNCT00538278
What this trial is testing

Prospective Database for Acute Myeloblastic Leukemia

Who this might be right for
Leukemia, Myeloblastic, Acute
King Faisal Specialist Hospital & Research Center 2,000
Testing effectiveness (Phase 2)Study completedNCT01175785
What this trial is testing

Infusion of Off-the-Shelf Expanded Cord Blood Cells to Augment Cord Blood Transplant in Patients With Hematologic Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities+17 more
Nohla Therapeutics, Inc. 15
Testing effectiveness (Phase 2)Study completedNCT00520208
What this trial is testing

Safety, Efficacy, & Pharmacokinetic Study of Tamibarotene to Treat Patients With Relapsed or Refractory APL

Who this might be right for
Acute Promyelocytic Leukemia
CytRx 15
Not applicableActive Not RecruitingNCT06764589
What this trial is testing

Liquid Micro-biopsy: a Novel Approach to Study Tumor Microenvironment From the Peripheral Blood

Who this might be right for
Acute Myelocytic Leukemia
IRCCS Azienda Ospedaliero-Universitaria di Bologna 90
Testing effectiveness (Phase 2)Study completedNCT01893320
What this trial is testing

Study of Vosaroxin and Decitabine in Older Patients With Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 66
Early research (Phase 1)Study completedNCT01001143
What this trial is testing

Intravenous (IV) Decitabine and Oral Bexarotene for Acute Myelogenous Leukemia (AML)

Who this might be right for
Leukemia, Myeloid, Acute
Washington University School of Medicine 19
Early research (Phase 1)Looking for participantsNCT06550713
What this trial is testing

A Clinical Trial of TQB3455 Tablets in Patients With Hematological Malignancies

Who this might be right for
Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome (MDS)
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 100
Testing effectiveness (Phase 2)Study completedNCT00049179
What this trial is testing

S0117 Gemtuzumab Ozogamicin Plus Cytarabine in Treating Patients With Relapsed Acute Myeloid Leukemia

Who this might be right for
Leukemia
SWOG Cancer Research Network 33
Not applicableUnknownNCT05512104
What this trial is testing

Clinical Characters and Outcome of Acute Myeloid Leukemia Patients on Correlation to CD200 and CD56 Expression

Who this might be right for
Acute Myeloid Leukemia
Assiut University 51
Testing effectiveness (Phase 2)Study completedNCT00071006
What this trial is testing

AG-013736 (Axitinib) In Patients With Poor Prognosis Acute Myeloid Leukemia (AML) Or Myelodysplastic Syndrome (MDS)

Who this might be right for
Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome
Pfizer 12
Very early researchStudy completedNCT02233504
What this trial is testing

Pilot Study to Assess Hematologic Response in Patients With Acute Myeloid Leukemia or High Risk Myelodysplastic Syndromes Undergoing Monotherapy With Exjade (Deferasirox)

Who this might be right for
High Risk MDS or AML Patients
Abramson Cancer Center at Penn Medicine 25
Testing effectiveness (Phase 2)Study completedNCT00195104
What this trial is testing

Arsenic Trioxide in Combination With Cytarabine in Patients With High-risk MDS and Poor-prognosis AML

Who this might be right for
Myelodysplastic Syndrome
Weill Medical College of Cornell University 87
Early research (Phase 1)Study completedNCT02040506
What this trial is testing

A Phase I Study of IGN523 in Subjects With Relapsed or Refractory AML

Who this might be right for
Acute Myelogenous LeukemiaAcute Myeloid Leukemia
Igenica Biotherapeutics, Inc. 19
Testing effectiveness (Phase 2)Study completedNCT01806571
What this trial is testing

Daunorubicin Hydrochloride, Cytarabine, and Nilotinib in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Untreated Adult Acute Myeloid Leukemia
Mayo Clinic 34
Not applicableNot Yet RecruitingNCT07319793
What this trial is testing

Pre-DLI or Pro-DLI in Relapsed/Refractory Myeloid Neoplasms After HSCT

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndromes (MDS)
Peking University People's Hospital 200
Very early researchLooking for participantsNCT06201247
What this trial is testing

Off-the-shelf CD123 CAR-NK for R/R AML

Who this might be right for
Acute Myeloid Leukemia, in RelapseAcute Myeloid Leukemia Refractory
Peking University People's Hospital 12
Testing effectiveness (Phase 2)Ended earlyNCT00947648
What this trial is testing

Outpatient Neutropenic Diet Study

Who this might be right for
LeukemiaNeutropenia
M.D. Anderson Cancer Center 30
Next Page